Loading market data...

Sai Life Sciences IPO

CDMO Pharma - Listed on 18 December 2024

+39.3% listing gain
Issue Price (Upper)
Rs 549
Listing Price
Rs 764.65
Closing Price (NSE)
Rs 764.65
Total Subscription
10.27x

Sai Life Sciences IPO listing summary

Sai Life Sciences (CDMO Pharma) closed its IPO window in 2024 and listed on NSE and BSE on 18 December 2024 at an upper band issue price of Rs 549, opening at Rs 764.65 for a listing gain of +39.3% and closing day one at Rs 764.65 (+39.3% on closing basis). The IPO was subscribed 10.27x overall - QIB 29.78x, HNI/NII 4.99x, Retail 1.39x. The total issue size was Rs 3,042.62 Cr (Fresh Issue Rs 950 Cr, OFS Rs 2092.62 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.

Listing day performance

Listing Gain (Open)
+39.28%
Listing Gain (Close)
+39.28%
Day Change After Listing
0.00%
Retail Quota
10.0%

Subscription breakdown

Final (Day 3) subscription

Number of times each investor category subscribed by close of Day 3.

QIB29.78x
HNI / NII4.99x
Retail1.39x
Overall10.27x

Day-wise overall subscription

How overall subscription built up across the three-day issue window.

Day 10.50x
Day 23.20x
Day 3 (Final)10.27x

Sai Life Sciences IPO GMP history

Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.

DayGMP (Rs)GMP %
Day 1Rs 400+7.65%
Day 2Rs 380+6.38%
Day 3Rs 400+4.01%
Day 4Rs 380+3.64%
Day 5Rs 400+3.64%

GMP Prediction vs IPOGyani AI Prediction

Comparison between market-based GMP prediction and IPOGyani's AI-powered listing gain prediction.

GMP Prediction Range
3.6%-7.7%
IPOGyani AI Prediction
-
Actual Listing Gain
+39.3%

Issue & financials

Issue SizeRs 3,042.62 Cr
Fresh IssueRs 950 Cr
OFSRs 2,092.62 Cr
IPO PE126.42
Peer / Sector PE50.00
PE vs Sector Ratio2.53
Latest EBITDA (Cr)400.00
Debt / Equity0.85

Market context at listing

How the broader market moved around the Sai Life Sciences IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.

Nifty 3D Return-0.18%
Nifty 1W Return-0.58%
Nifty 1M Return+4.68%
Nifty during IPO window+0.55%

Sai Life Sciences IPO - FAQs

What was the listing gain of Sai Life Sciences IPO?

Sai Life Sciences IPO listed at +39.3% versus the upper issue price of Rs 549 on 18 December 2024.

How many times was Sai Life Sciences IPO subscribed?

Sai Life Sciences IPO was subscribed 10.27x overall. QIB portion was subscribed 29.78x, HNI / NII 4.99x and Retail 1.39x.

What was the IPO GMP for Sai Life Sciences?

IPO GMP started at Rs 400 on Day 1 and moved to Rs 400 by the close of the issue window. See the day-by-day GMP table above for the full trajectory.

Other IPOs listed in 2024

Browse listed IPOs by year